HIV latency-resistant effective part of euphorbia and use thereof

An effective part, Euphorbia technology, applied in the field of medicine, can solve the problems of large toxic and side effects, unsatisfactory and other problems
CN102727563AActive Publication Date: 2012-10-17SHANGHAI XINHAO BIOLOGICAL TECH
1 Cites 9 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SHANGHAI XINHAO BIOLOGICAL TECH
Publication Date
2012-10-17

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a HIV latency-resistant effective part of euphorbia and a use thereof. Through an ingenious activity screening method, it is found that a traditional Chinese medicine euphorbia has effects of resisting AIDS. Through solvent extraction, extraction and column chromatography processes and the combination with activity screening, the HIV latency-resistant effective part of euphorbia is determined and is prepared; and the HIV latency-resistant effective part of euphorbia can be used as an active ingredient having effects of resisting AIDS. The HIV latency-resistant effective part of euphorbia has effects of HIV latency intervention, can be combined with antiretroviral drugs thereby promoting removal of latent virus reservoirs, and provides a novel approach for thorough curing of AIDS.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicine, and relates to the discovery of an effective part of an active traditional Chinese medicine and its preparation method, as well as its application in anti-HIV latent treatment. Background technique

[0002] Acquired Immunodeficiency Syndrome (AIDS) is an infectious disease caused by HIV infection that seriously endangers people's life and health. According to WHO statistics, there are more than 40 million AIDS patients in the world, with 5 million new patients and 3 million deaths each year.

[0003] At present, the clinical treatment of AIDS is mainly Highly active antiretroviral therapy (HAART), which not only effectively controls HIV replication, but also can rebuild the immune function of AIDS patients, opening the door of hope for the treatment of AIDS .

[0004] People once hoped to completely eliminate HIV in the body by virtue of HAART, so as to achieve the goal of completely curing AIDS. Howev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More